Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
The study findings confirm the long-term efficacy and safety of biosimilar in patients with PNH.
Authors
- Н. В. Минаева (ORCID: https://orcid.org/0000-0002-8479-3217)
- Alexander Kulagin (ORCID: https://orcid.org/0000-0002-9589-4136)
- О. А. Markova (ORCID: https://orcid.org/0000-0002-1179-3881)
- Elena Lukina (ORCID: https://orcid.org/0000-0002-8774-850X)
- Eugene V. Zuev (ORCID: https://orcid.org/0000-0002-2787-8118)
- Vitalii D. Latyshev (ORCID: https://orcid.org/0000-0003-0643-8807)
- В. В. Птушкин (ORCID: https://orcid.org/0000-0002-9368-6050)
- Т. А. Митина (ORCID: https://orcid.org/0000-0001-7493-0030)
- И. Л. Давыдкин (ORCID: https://orcid.org/0000-0002-4318-4247)
- Olesya Klimova (ORCID: https://orcid.org/0000-0001-7238-729X)
- Tatiana S. Konstantinova (ORCID: https://orcid.org/0000-0003-4687-0784)
- E. G. Arshanskaya
- Alexander Korobkin
- Elena Yu. Komartseva
Institutions
- First Pavlov State Medical University of St. Petersburg (RU)
- Regional Clinical Hospital No 4 (RU)
- National Medical Research Center for Hematology (RU)
- Kirov Research Institute of Hematology and Blood Transfusion FMBA (RU)
- Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky (RU)
- Botkin Hospital (RU)
- Samara State Medical University (RU)
- Regional Clinical Research (US)
- Regional Children's Clinical Hospital No. 1 (RU)
- Regional Children's Hospital No1 (RU)
- Rostov Research Institute of Oncology (RU)
- Chelyabinsk Regional Clinical Oncology Center (RU)
- Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" (RU)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1159/000542294
- Citations
- 2
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.48